Learn about a treatment regimen for advanced breast cancer

PERJETA is a first-line treatment for HER2-positive (HER2+) breast cancer that has spread to other parts of the body (metastasized). Cancer that has metastasized can be called “metastatic” or “advanced” cancer. If you’ve been diagnosed with HER2+ metastatic breast cancer, adding PERJETA to Herceptin® (trastuzumab) and docetaxel provides a dual blockade against HER2 signaling.

How PERJETA is given

PERJETA is given in combination with Herceptin® (trastuzumab) and docetaxel.

PERJETA for HER2+ metastatic breast cancer

See the potential benefits and risks associated with PERJETA for HER2+ metastatic breast cancer.

Talking with your team

Some tips on how to get the most out of your appointments with your healthcare team.

HERConnection Program

A free program that provides PERJETA information and resources to patients.